MANHManhattan Associates, Inc.

Filed with the SEC on October 27, 2026 | Price: $246.88 | Today's Change: +5.51%

---

What Happened

Manhattan Associates filed an 8-K with the SEC on October 27, 2026, covering an unusually broad set of disclosure items — including a completed acquisition (Item 2.01), a change to stockholder rights (Item 3.03), executive changes (Item 5.02), an amendment to the company's governing documents (Item 5.03), a regulation FD disclosure (Item 7.01), and financial exhibits (Item 9.01). Alongside these governance and structural disclosures, the filing contains Q2 FY2026 financial results showing revenue of $535,208,000, net income of $109,362,000, operating income of $136,960,000, and diluted EPS of $1.78. The breadth of items triggered in a single 8-K signals a period of meaningful corporate activity, not merely a routine financial update.

---

Why It Matters

For investors, this filing represents several simultaneous moving parts that deserve close attention:

• Revenue scale: Q2 FY2026 revenue of $535.2 million demonstrates the company's continued growth trajectory. For context, XBRL data from this filing also references revenues of $110.8 million in FY2015, underscoring how dramatically the top line has expanded over the past decade.
• Profitability: Operating income of $136.96 million and net income of $109.36 million reflect healthy operating margins for the quarter, with diluted EPS coming in at $1.78.
• Governance activity: The simultaneous triggering of Items 2.01, 3.03, 5.02, and 5.03 suggests the company completed an acquisition, made leadership changes, and amended its charter or bylaws — all in the same reporting window. Each of these items independently carries potential implications for future strategy, capital allocation, and management direction.
• Stock reaction: The shares are up 5.51% on the day, which is consistent with the market responding positively to the combination of the financial results and the strategic disclosures.

This follows StockWatch's existing initiating coverage on MANH, published October 12, 2026, which provided a detailed fundamental framework for evaluating the company — readers are encouraged to review that report alongside this update.

---

Analysis

The sheer number of 8-K items filed simultaneously is the first thing to flag. An 8-K that triggers Items 2.01 (completion of acquisition), 3.03 (material modification to rights of security holders), 5.02 (executive departure or appointment), and 5.03 (amendments to charter/bylaws) all at once is not routine. It suggests Manhattan Associates has executed a transaction and restructured aspects of its corporate governance in conjunction with it — a pattern worth watching closely as additional details emerge from the full exhibits.

On the financials, the Q2 FY2026 numbers are strong in absolute terms. Revenue of $535.2 million and operating income of nearly $137 million point to a business generating substantial cash-flow-level earnings from operations. The diluted EPS of $1.78 provides a clean per-share metric for investors tracking earnings power.

The stock's +5.51% move today suggests the market is reading both the financial results and the strategic announcements as net positives. Key items to watch as more detail becomes available: the specific nature and terms of the completed acquisition disclosed under Item 2.01, who the executive changes under Item 5.02 involve and in what capacity, and precisely what governance modifications were made under Items 3.03 and 5.03 — as these could affect shareholder rights in material ways.

---

Disclaimer

This report is a news and informational summary based solely on data extracted from Manhattan Associates' SEC filing (8-K filed October 27, 2026) and publicly available stock price data. It does not constitute investment advice, a solicitation to buy or sell any security, or an equity research recommendation of any kind. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions. Financial figures cited are sourced directly from the filing's official XBRL data.

Existing Coverage

StockWatch has full coverage on MANH, published 2026-10-12. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-10-27. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1056696/000119312526434178/manh-20261027.htm